(ADAP) Adaptimmune - Performance -78.1% in 12m
ADAP performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-92.41%
#192 in Peer-Group
Rel. Strength
3.46%
#7420 in Stock-Universe
Total Return 12m
-78.07%
#171 in Peer-Group
Total Return 5y
-96.83%
#158 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 1.39 USD |
| 52 Week Low | 0.20 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 84.63 |
| Buy/Sell Signal +-5 | 1.57 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ADAP (-78.1%) vs XBI (-11.6%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-1.6% | 59% | 71.9% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
3.16% | -9.04% | 157% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-1.03% | -8.54% | 32.3% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| NBIX NASDAQ Neurocrine Biosciences |
8.1% | -8.36% | 1.32% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| BIM PA Biomerieux |
-0.99% | 26.5% | -5.28% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
8.81% | 38.5% | -10.4% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.65% | 49.3% | -10.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
-1.76% | 27.6% | 14.6% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ADAP vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ADAP
| Total Return (including Dividends) | ADAP | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 7.40% | 5.89% | 3.54% |
| 3 Months | 9.42% | 15.34% | 16.07% |
| 12 Months | -78.07% | -11.61% | 12.18% |
| 5 Years | -96.83% | -23.80% | 107.69% |
| Trend Score (consistency of price movement) | ADAP | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 30.9% | 65.7% | 91.4% |
| 3 Months | -18.3% | 79.4% | 97.5% |
| 12 Months | -95.3% | -87.3% | 46.7% |
| 5 Years | -92.9% | -51.8% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th69.00 | 4.21% | 3.73% |
| 3 Month | %th52.00 | -2.52% | -5.73% |
| 12 Month | %th14.50 | -74.51% | -80.45% |
| 5 Years | %th22.50 | -95.63% | -98.47% |
FAQs
Does Adaptimmune (ADAP) outperform the market?
No,
over the last 12 months ADAP made -78.07%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.61%.
Over the last 3 months ADAP made 9.42%, while XBI made 15.34%.
Performance Comparison ADAP vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ADAP vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 7.6% | 3.9% | -60.6% | -90% |
| US NASDAQ 100 | QQQ | 7.2% | 3.2% | -65.5% | -91% |
| German DAX 40 | DAX | 7.5% | 5.5% | -73.7% | -107% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 7.1% | 2.5% | -64.6% | -98% |
| Hongkong Hang Seng | HSI | 7% | 5% | -82.6% | -112% |
| India NIFTY 50 | INDA | 8.7% | 6.7% | -62.9% | -75% |
| Brasil Bovespa | EWZ | 12.2% | 10.4% | -72.7% | -79% |
ADAP vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 7.9% | 4.6% | -67.7% | -103% |
| Consumer Discretionary | XLY | 6.2% | 3.3% | -55.8% | -95% |
| Consumer Staples | XLP | 9.4% | 7.1% | -62.1% | -86% |
| Energy | XLE | 5.6% | 6.2% | -53.2% | -77% |
| Financial | XLF | 8.2% | 3.1% | -64.7% | -102% |
| Health Care | XLV | 7.4% | 7.4% | -52.3% | -71% |
| Industrial | XLI | 6.5% | 1.9% | -68.1% | -101% |
| Materials | XLB | 7.3% | 3.6% | -61.6% | -81% |
| Real Estate | XLRE | 7% | 6.7% | -61.2% | -86% |
| Technology | XLK | 7.6% | 2% | -67.7% | -88% |
| Utilities | XLU | 7% | 4.5% | -66% | -101% |
| Aerospace & Defense | XAR | 4.9% | -2.5% | -83.6% | -128% |
| Biotech | XBI | 2.3% | 1.5% | -56.9% | -66% |
| Homebuilder | XHB | 5.1% | -1.9% | -52.8% | -74% |
| Retail | XRT | 6.8% | 2.3% | -59.7% | -85% |
ADAP vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 9% | 11.2% | -47.6% | -72% |
| Natural Gas | UNG | 6.7% | 17.4% | -37.8% | -84% |
| Gold | GLD | 7.1% | 9% | -78.3% | -115% |
| Silver | SLV | 4.3% | 2.6% | -82.4% | -102% |
| Copper | CPER | 6.3% | -6.2% | -79.4% | -101% |
ADAP vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 8.5% | 6.9% | -57.6% | -74% |
| iShares High Yield Corp. Bond | HYG | 8.1% | 6.5% | -58.7% | -87% |